- Home
- PLRX vs VIDA Comparison
PLRX vs VIDA Comparison
Compare PLRX & VIDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.13
N/A
Current Price
$2.46
Company Overview
Basic Information| Metric | PLRX | VIDA |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.6M | 64.7M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PLRX | VIDA |
|---|---|---|
| Price | $1.13 | $2.46 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 437.4K | 118.4K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $2.06 |
| 52 Week High | $1.95 | $4.25 |
Technical Indicators
Market Signals| Indicator | PLRX | VIDA |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 17.24 |
| Support Level | $1.12 | $2.06 |
| Resistance Level | $1.37 | N/A |
| Average True Range (ATR) | 0.04 | 0.47 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 26.67 | 16.44 |
Price Performance
Historical Comparison PLRX
VIDA
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.